GlassScriptPhysician profile
Justin Weirich
NPI 1992154686
$7,959.34
in general payments reported to CMS, 2019-2025
45 companies · $1,339 in 2025
The $1,339 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $863 · 2021: $1,461 · 2022: $1,189 · 2023: $1,084 · 2024: $1,667 · 2025: $1,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,089.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,514.94 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Novo Nordisk INC | $1,022.64 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $977.26 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $581.66 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $482.75 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $366.66 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $236.97 | 2020-2024 | Belsomra, Steglatro, Vaxneuvance |
| Corium, LLC | $193.59 | 2022-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $185.34 | 2020-2025 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $176.06 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $172.40 | 2020-2025 | Arexvy, Shingrix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $141.37 | 2025 | Caplyta |
| Axsome Therapeutics, INC. | $140.02 | 2023-2025 | Auvelity, Symbravo |
| Amgen INC. | $139.91 | 2019-2025 | Otezla, Repatha, Otezla |
| Medtronic, INC. | $139.76 | 2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Weirich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.